Theory and Treatment of the X-Inactivation Chimera in Female-Prevalent Autoimmune Disease

Archivum Immunologiae et Therapiae Experimentalis

Volumn 47, Issue 6, 1999, Pages 355-359

  Stewart, Jeffrey J ^a,b  

^a PRINCETON UNIVERSITY   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Chimerism; Dendritic cells; Sj gren's syndrome; Systemic autoimmune disease; Systemic lupus erythematosus; X chromosome inactivation

Indexed keywords

ANIMAL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOLOGICAL MODEL; CHIMERA; DISEASE MODEL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MONOZYGOTIC TWINS; MOUSE; REVIEW; T LYMPHOCYTE; TWINS;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHIMERA; DISEASE MODELS, ANIMAL; DISEASES IN TWINS; DOSAGE COMPENSATION, GENETIC; FEMALE; HUMANS; IMMUNOSUPPRESSION; MALE; MICE; MODELS, GENETIC; SELF TOLERANCE; T-LYMPHOCYTES; TWINS, MONOZYGOTIC;

EID: 0345807658     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. ARACTINGI S., BERKANE N., BERTHEAU P., LE GOUE C., DAUSSET J., UZAN S. and CAROSELLA E. D. (1998): Fetal DNA in skin of polymorphic eruptions of pregnancy. Lancet, 352, 1898-1901.
2. ARTLETT C. M., SMITH J. B. and JIMENEZ S. A. (1998): Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N. Engl. J. Med., 338, 1186-1191.
3. BELGHITI D., RAZAVI-ENCHA F., RAOUL O., HIRBEC G., GUILLOT F., REINERT P. and SOBEL A. (1986): Coincidence of familial systemic lupus erythematosus and the fragile X syndrome. Ann. Genet., 29, 261-263.
4. BELMONT J. W. (1996): Genetic control of X inactivation and processes leading to X-inactivation skewing. Am. J. Hum. Genet., 58, 1101-1108.
5. BURT R. K., TRAYNOR A. E., POPE R., SCHROEDER J., COHEN B., KARLIN K. H., LOBECK L., GOOLSBY C., ROWLINGS P., DAVIS F. A., STEFOSKI D., TERRY C., KEEVER-TAYLOR C., ROSEN S., VESOLE D., FISHMAN M., BRUSH M., MUJIAS S., VILLA M. and BURNS W. H. (1998): Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood, 92, 3505-3514.
6. BUSQUE L., MIO R., MATTIOLI J., BRAIS E., BLAIS N., LALONDE Y., MARAGH M. and GILLILAND D. G. (1996): Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood, 88, 59-65.
7. DEAPEN D., ESCALANTE A., WEINRIB L., HORWITZ D., BACHMAN B., ROY-BURMAN P., WALKER A. and MACK T. M. (1992): A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum., 35, 311-318.
8. EVANS P. C., LAMBERT N., MALONEY S., FURST D. E., MOORE J. M. and NELSON J. L. (1999): Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood, 93, 2033-2037.
9. FEY M. F., LIECHTI-GALLATI S., VON ROHR A., BORISCH B., THEILKAS L., SCHNEIDER V., OESTREICHER M., NAGEL S., ZIEMIECKI A. and TOBLER A. (1994): Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe. Blood, 83, 931-938.
10. FEY M. F., PETER H. J., HINDS H. L., ZIMMERMANN A., LIECHTI-GALLATI S., GERBER H., STUDER H. and TOBLER A. (1992): Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe. J. Clin. Invest., 89, 438-444.
11. FURST D. E., CLEMENTS P. J., GRAZE P., GALE R. and ROBERTS N. (1979): A syndrome resembling progressive systemic sclerosis after bone marrow transplantation. A model for scleroderma? Arthritis Rheum., 22, 904-910.
12. GALE R. E., FIELDING A. K., HARRISON C. N. and LINCH D. C. (1997): Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age. Br. J. Haematol., 98, 512-519.
13. GALE R. E., WHEADON H., BOULOS P. and LINCH D. C. (1994): Tissue specificity of X-chromosome inactivation patterns. Blood, 83, 2899-2905.
14. GALE R. E., WHEADON H. and LINCH D. C. (1991): X-chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post-chemotherapy females. Br. J. Haematol., 79, 193-197.
15. GALE R. E., WHEADON H. and LINCH D. C. (1992): Assessment of X-chromosome inactivation patterns using the hypervariable probe M27 beta in normal hemopoietic cells and acute myeloid leukemic blasts. Leukemia, 6, 649-655.
16. GLEICHMANN E., VAN ELVEN E. H. and VAN DER VEEN J. P. (1982): A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur. J. Immunol., 12, 152-159.
17. GREGERSEN P. K. (1993): Discordance for autoimmunity in monozygotic twins: Are "identical" twis really identical? Arthritis Rheum., 36, 1185-1192.
18. GREGERSEN P. K., CHITNIS S. and MONTEIRO J. (1999): Increased X-inactivation skewing in SLE? Immunol. Today, 20, 152.
19. + T cells. J. Exp. Med., 186, 801-812.
20. HARRIS A., COLLINS J., VETRIE D., COLE C. and BOBROW M. (1992): X inactivation as a mechanism of selection against lethal alleles: further investigation of incontinentia pigmenti and X linked lymphoproliferative disease. J. Med. Genet., 29, 608-614.
21. HART D. N. J. (1997): Dendritic cells: unique leukocyte populations which control the primary immune response. Blood, 90, 3245-3287.
22. HUANG Q., PARFITT A., GRENNAN D. M. and MANOLIOS N. (1997): X-chromosome inactivation in monozygotic twins with systemic lupus erythematosus. Autoimmunity, 26, 85-93.
23. KANEKO H., INOUE R., YAMADA Y., SUKEGAWA K., FUKAO T., TASHITA H., TERAMOTO T., KASAHARA K., TAKAMI T. and KONDO N. (1996): Microsatellite instability in B-cell lymphoma originating from Bloom syndrome. Int. J. Cancer, 69, 480-483.
24. KAST R. E. (1977): Predominance of autoimmune and rheumatic diseases in females. J. Rheumatol., 4, 288-292.
25. KHOURY S. J., GALLON L., CHEN W., BETRES K., RUSSELL M. E., HANCOCK W. W., CARPENTER C. B., SAYEGH M. H. and WEINER H. L. (1995): Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J. Exp. Med., 182, 357-366.
26. KOTZIN B. L., BABCOCK S. K. and HERRON L. R. (1988): Deletion of potentially self-reactive T cell receptor specificities in L3T4-, Lyt-2-T cells of lpr mice [published erratum appears in J. Exp. Med. 1989 Apr 1; 169 (4): 1515-1516]. J. Exp. Med., 168, 2221-2229.
27. KOTZIN B. L., KAPPLER J. W., MARRACK P. C. and HERRON L. R. (1989): T cell tolerance to self antigens in New Zealand hybrid mice with lupus-like disease. J. Immunol., 143, 89-94.
28. KRANCE R. and BRENNER M. (1998). BMT beats autoimmune disease. Nat. Med., 4, 153-155.
29. LAWLEY T. J., PECK G. L., MOUTSOPOULOS H. M., GRATWOHL A. A. and DEISSEROTH A. B. (1977): Scleroderma, Sjögren-like syndrome, and chronic graft-versus-host disease. Ann. Intern. Med., 87, 707-709.
30. LOCKSHIN M. D. (1998): Why women? J. Am. Med. Wom. Assoc., 53, 4-8.
31. LYON M. F. (1992): Some milestones in the history of X-chromosome inactivation. Annu. Rev. Genet., 26, 16-28.
32. MERCHANT P. C. and SHAHANI S. M. (1989): Klinefelter's syndrome. An immunological disorder. Andrologia, 21, 476-478.
33. MILLS J. A. (1994): Systemic lupus erythematosus [see comments]. N. Engl. J. Med., 330, 1871-1879.
34. MONTEIRO J., DEROM C., VLIETINCK R., KOHN N., LESSER M. and GREGERSEN P. K. (1998): Commitment to X inactivation precedes the twinning event in monochorionic MZ twins. Am. J. Hum. Genet., 63, 339-346.
35. MOZES E. and FUCHS S. (1974): Linkage between immune response potential to DNA and X chromosome. Nature, 249, 167-168.
36. MULLINAX F. (1998): Chimerism in scleroderma. Lancet, 351, 1886.
37. MULLINAX F. and MULLINAX G. L. (1996): Pregnancy-induced scleroderma. Identification of offspring-derived cells in patients with scleroderma. Arthritis Rheum., 39, S231.
38. NAUMOVA A. K., OLIEN L., BIRD L. M., SMITH M., VERNER A. E., LEPPERT M., MORGAN K. and SAPIENZA C. (1998): Genetic mapping of X-linked loci involved in skewing of X chromosome inactivation in the human. Eur. J. Hum. Genet., 6, 552-562.
39. NAUMOVA A. K., PLENGE R. M., BIRD L. M., LEPPERT M., MORGAN K., WILLARD H. F. and SAPIENZA C. (1996): Heritability of X chromosome-inactivation phenotype in a large family. Am. J. Hum. Genet., 58, 1111-1119.
40. NELSON J. L., FURST D. E., MALONEY S., GOOLEY T., EVANS P. C., SMITH A., BEAN M. A., OBER C. and BIANCHI D. W. (1998): Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet, 351, 559-562.
41. PRCHAL J. T., PRCHAL J. F., BELICKOVA M., CHEN S., GUAN Y., GARTLAND G. L. and COOPER M. D. (1996): Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism. J. Exp. Med., 183, 561-567.
42. PUCK J. M., STEWART C. C. and NUSSBAUM R. L. (1992): Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency. Am. J. Hum. Genet., 50, 742-748.
43. ROZZO S. J., DRAKE C. G., CHIANG B. L., GERSHWIN M. E. and KOTZIN B. L. (1994): Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus. J. Immunol., 153, 1340-1351.
44. RUDENSKY A. Y., PRESTON-HURLBURT P., HONG S. C., BARLOW A. and JANEWAY C. A. (1991): Sequence analysis of peptides bound to MHC class II molecules. Nature, 353, 622-627.
45. SCHATTNER A. and BERREBI A. (1989): Klinefelter's syndrome associated with autoimmune disease. J. R. Soc. Med., 82, 560.
46. SCOTT D. E., KISCH W. J. and STEINBERG A. D. (1993): Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J. Immunol., 150, 664-672.
47. SIKAND G. S., TAYSI K., STRANDJORD S. E., GRIFFITH R. and VIETTI T. J. (1980): Trisomy 21 in bone marrow cells of a patient with a prolonged preleukemic phase. Med. Pediatr. Oncol., 8, 237-242.
48. STEWART J. J. (1998): The female X-inactivation mosaic in systemic lupus erythematosus. Immunol. Today, 19, 352-357.
49. STEWART J. J. (1999): Reply to Gregersen et al. and Takeno et al. Immunol. Today, 20, 153.
50. TAKENO M., KASHIWAKURA J. and SAKANE T. (1999): The female X-inactivalion mosaic in SLE. Immunol. Today, 20, 152-153.
51. TAKENO M., NAGAFUCHI H., KANEKO S., WAKISAKA S., ONEDA K., TAKEBA Y. YAMASHITA N., SUZUKI N., KANEOKA H. and SAKANE T. (1997): Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. J. Immunol., 158, 3529-3538.
52. TONEGAWA S. M. S. (1997): Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide. J. Exp. Med., 186, 507-515.
53. TONON L., BERGAMASCHI G., DELLAVECCHIA C., ROSTI V., LUCOTTI C., MALABARBA L., NOVELLA A., VERCESI E., FRASSONI F. and CAZZOLA M. (1998): Unbalanced X-chromosome inactivation in haemopoietic cells from normal women. Br. J. Haematol., 102, 996-1003.
54. TREJO V., DEROM C., VLIETINCK R., OLLIER W., SILMAN A., EBERS G., DEROM R. and GREGERSEN P. K. (1994): X chromosome inactivation patterns correlate with fetal-placental anatomy in monozygotic twin pairs: implications for immune relatedness and concordance for autoimmunity. Mol. Med., 1, 62-70.
55. TYNDALL A. and GRATWOHL A. (1997): Heinopoietic blood and marrow transplants in the treatment of severe autoimmune disease. Curr. Opin. Hematol., 4, 390-394.
56. 1 mice: a new model of lupus-like disease. J. Exp. Med., 179, 1429-1435.
57. VOGELSTEIN B., FEARON E. R., HAMILTON S. R., PREISINGER A. C., WILLARD H. F., MICHELSON A. M., RIGGS A. D. and ORKIN S. H. (1987): Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res., 47, 4806-4813.
58. VONDERHEID E. C., KOBLENZER P. J., MING P. M. and BURGOON C. F. JR. (1976): Neonatal lupus erythematosus. Report of four cases with review of the literature. Arch. Dermatol., 112, 698-705.